Chondroitin sulfate ( DrugBank: Chondroitin sulfate, Sulfate )

---

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	1
226	間質性膀胱炎（ハンナ型）	4

96. クローン病

---

臨床試験数 : 2,442 /  薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01245088 (ClinicalTrials.gov)	January 2011	19/11/2010	Chondroitin Sulfate for Crohn's Disease	A Pilot Study of Chondroitin Sulfate (CS) for the Treatment of Mild to Moderate Crohn's Disease	Crohn's Disease	Drug: chondroitin sulfate	University Hospital Case Medical Center	NULL	Withdrawn	18 Years	80 Years	Both	0	Phase 1/Phase 2	United States

226. 間質性膀胱炎（ハンナ型）

---

臨床試験数 : 145 /  薬物数 : 156 - (DrugBank : 51) / 標的遺伝子数 : 64 - 標的パスウェイ数 : 146

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03463499 (ClinicalTrials.gov)	September 22, 2017	25/2/2018	The Efficacy and Safety of Intravesical Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients	The Efficacy and Safety of Intravesical Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients	Interstitial Cystitis	Drug: Hyaluronic Acid and Chondroitin Sulfate	Samsung Medical Center	NULL	Completed	20 Years	N/A	All	62	N/A	Korea, Republic of
2	NCT01813565 (ClinicalTrials.gov)	March 20, 2013	11/3/2013	The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome.	The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome.	Interstitial Cystitis	Drug: Hyaluronic acid/chondroitin sulfate	Asan Medical Center	NULL	Terminated	20 Years	N/A	All	15	N/A	Korea, Republic of
3	EUCTR2010-021556-25-IT (EUCTR)	24/02/2011	04/11/2010	Phase III, randomized, open-label, multicenter evaluation of efficacy and tolerability `of Ialuril (sodium hyaluronate-chondroitin sulfate) vs. dimethyl sulfoxide (DMSO) in women with interstitial cystitis / painful bladder syndrome (IC / BPS)AscoltaTrascrizione foneticaDizionario - Visualizza dizionario dettagliato - IBSA 01-2010	Phase III, randomized, open-label, multicenter evaluation of efficacy and tolerability `of Ialuril (sodium hyaluronate-chondroitin sulfate) vs. dimethyl sulfoxide (DMSO) in women with interstitial cystitis / painful bladder syndrome (IC / BPS)AscoltaTrascrizione foneticaDizionario - Visualizza dizionario dettagliato - IBSA 01-2010	Interstitial Cystitis MedDRA version: 9.1;Level: HLGT;Classification code 10018188	Trade Name: RIMSO 50 INN or Proposed INN: Dimethyl sulfoxide	IBSA	NULL	Not Recruiting			Female: yes Male: no		Phase 3	Italy
4	NCT00919113 (ClinicalTrials.gov)	July 2009	11/6/2009	Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome	A Multi-Center, Randomized, Double-Blind, Parallel Group Evaluation of the Effectiveness and Safety of Uracyst® Compared to Inactive Control in Subjects With Interstitial Cystitis/Painful Bladder Syndrome	Interstitial Cystitis;Painful Bladder Syndrome	Drug: 2% sodium chondroitin sulfate;Drug: Placebo	Watson Pharmaceuticals	NULL	Completed	18 Years	N/A	Female	98	Phase 2	United States

先頭へ